相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Black African and Latino/a identity correlates with increased plasmablasts in MS
Kiel M. Telesford et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
Fabienne Largey et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis
E. R. Petersen et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
FRONTIERS IN IMMUNOLOGY (2019)
T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate
Wataru Ise et al.
IMMUNITY (2018)
Reassessing B cell contributions in multiple sclerosis
Rui Li et al.
NATURE IMMUNOLOGY (2018)
B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTα and TGFβ1 response
Oskar McWilliam et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Synaptic interactions in Germinal Centers
Ilenia Papa et al.
FRONTIERS IN IMMUNOLOGY (2018)
Characterization of naive, memory and effector T cells in progressive multiple sclerosis
Birgitte Romme Nielsen et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis
Finn Sellebjerg et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood
Tam D. Quach et al.
JOURNAL OF IMMUNOLOGY (2016)
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
Clemens Warnke et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The generation of antibody-secreting plasma cells
Stephen L. Nutt et al.
NATURE REVIEWS IMMUNOLOGY (2015)
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients
Damiano Rovituso et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study
R. Mancuso et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Natalizumab in progressive MS Results of an open-label, phase 2A, proof-of-concept trial
Jeppe Romme Christensen et al.
NEUROLOGY (2014)
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A. Harrer et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
Rebecca C. Selter et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen et al.
PLoS One (2013)
Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Luisa M. Villar et al.
ARCHIVES OF NEUROLOGY (2012)
Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
Raquel Planas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
Felipe von Glehn et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
B cells undergo unique compartmentalized redistribution in multiple sclerosis
Juergen Haas et al.
JOURNAL OF AUTOIMMUNITY (2011)
HLA-DRhigh/CD27(high) plasmablasts indicate active disease in patients with systemic lupus erythematosus
A. M. Jacobi et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression
Stephen M. Jackson et al.
BLOOD (2009)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
M. Krumbholz et al.
NEUROLOGY (2008)
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve et al.
ANNALS OF NEUROLOGY (2006)
Natalizumab effects on immune cell responses in multiple sclerosis
M Niino et al.
ANNALS OF NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
S Cepok et al.
BRAIN (2005)
Molecular pathways in bone marrow homing:: dominant role of α4β1 over β2-integrins and selectins
T Papayannopoulou et al.
BLOOD (2001)
分享论文
